Related Experiment Video
Updated: Jan 6, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.4K
Technological advances in the search for a CURE for asthma
Sara Quon1, Timothy M Johanson1, Ridhima Wadhwa2
1Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC.
The Medical Journal of Australia
|November 16, 2025
Summary
Defining asthma subtypes is crucial for reducing disease prevalence. Advanced profiling technologies and artificial intelligence offer new ways to achieve precision diagnoses and personalized asthma treatments.
Area of Science:
- Respiratory medicine
- Immunology
- Computational biology
Background:
- Asthma is a chronic respiratory disease affecting over 250 million people globally.
- It is a heterogeneous condition with diverse symptoms, severity, and underlying mechanisms.
- Targeted biologic therapies have shown long-term remission in specific asthma subgroups.
Purpose of the Study:
- To highlight the importance of accurately defining asthma subgroups for disease reduction.
- To explore the potential of advanced profiling technologies and artificial intelligence (AI) in asthma classification.
- To discuss the challenges in implementing these technologies in clinical practice.
Main Methods:
- Utilizing multi-analyte profiling technologies for comprehensive disease characterization.
- Applying artificial intelligence algorithms for accurate asthma subtype classification.
- Analyzing the potential for precision diagnostics and personalized treatment strategies.
Main Results:
- Advanced technologies enable detailed profiling of analytes for asthma classification.
- AI integration facilitates more precise disease prediction and diagnosis.
- Personalized treatment approaches can be developed based on identified asthma subtypes.
Conclusions:
- Accurate asthma subgroup definition is essential for effective disease management.
- Technological advancements and AI integration are key to personalized asthma care.
- Prioritizing and implementing these innovations in clinical settings is a critical next step.
Related Concept Videos
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Inhaled Medications
679
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
679
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K

